Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy.

OBJECTIVE This guideline summarizes the quality of the evidence to date and provides a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy (HDP). EVIDENCE The literature reviewed included the original HDP guidelines and their reference lists and an update from 1995. Using key words, Medline was searched for literature published between 1995 and 2007. Articles were restricted to those published in French or English. Recommendations were evaluated using the criteria of the Canadian Task Force on Preventive Health Care (Table 1). SPONSORS This guideline was developed by the Society of Obstetricians and Gynaecologists of Canada and was partly supported by an unrestricted educational grant from the British Columbia Perinatal Health Program (formerly the British Columbia Reproductive Care Program or BCRCP). The Canadian Hypertension Society provided assistance with the literature search and some travel support for one author. Much of the Canadian research cited in this document has been funded by the Canadian Institutes of Health Research. The potential for ongoing support is gratefully acknowledged.

[1]  A. Caughey,et al.  The use of ultrasound to detect small-for-gestational-age infants in patients with elevated human chorionic gonadotropin on maternal serum screening. , 2010, American journal of perinatology.

[2]  S. Zubrick,et al.  Hypertensive diseases of pregnancy and the development of behavioral problems in childhood and adolescence: the Western Australian Pregnancy Cohort Study. , 2009, The Journal of pediatrics.

[3]  Y. Poel,et al.  Psychological treatment of women with psychological complaints after pre-eclampsia , 2009, Journal of psychosomatic obstetrics and gynaecology.

[4]  Gary L Darmstadt,et al.  Reducing stillbirths: screening and monitoring during pregnancy and labour , 2009, BMC pregnancy and childbirth.

[5]  R. Newman,et al.  A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. , 1999, American journal of obstetrics and gynecology.

[6]  G Koren,et al.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis , 2000, The Lancet.

[7]  D. Towner,et al.  Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. , 2006, American journal of obstetrics and gynecology.

[8]  D. Henderson-smart,et al.  A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial. , 2007, The Australian & New Zealand journal of obstetrics & gynaecology.

[9]  J. Canick,et al.  Second-Trimester Levels of Maternal Serum Human Chorionic Gonadotropin and Inhibin A as Predictors of Preeclampsia in the Third Trimester of Pregnancy , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[10]  J. Troendle,et al.  Risks of hypertensive disorders in the second pregnancy. , 2001, Paediatric and perinatal epidemiology.

[11]  J. Lumley,et al.  Interventions for promoting smoking cessation during pregnancy. , 2004, The Cochrane database of systematic reviews.

[12]  R. Hermida,et al.  Administration Time–Dependent Influence of Aspirin on Blood Pressure in Pregnant Women , 2003, Hypertension.

[13]  Kypros H Nicolaides,et al.  An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. , 2005, American journal of obstetrics and gynecology.

[14]  S. Millard,et al.  Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. , 1999, Obstetrics and gynecology.

[15]  Jan Pryor,et al.  Perinatal predictors of neurodevelopmental outcome in small-for-gestational-age children at 18 months of age. , 2002, American journal of obstetrics and gynecology.

[16]  K. Leveno,et al.  Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? , 1999, Obstetrics and gynecology.

[17]  D. Taylor,et al.  Hypertension in Pregnancy: Which Method of Blood Pressure Measurement is Most Predictive of Outcome? , 1996, Obstetrics and gynecology.

[18]  R. Bortolus,et al.  Nifedipine administered in pregnancy: effect on the development of children at 18 months , 2000, BJOG : an international journal of obstetrics and gynaecology.

[19]  S. Twaddle,et al.  Screening and surveillance of pregnancy hypertension--an economic approach to the use of daycare. , 1990, Bailliere's clinical obstetrics and gynaecology.

[20]  L. Butters,et al.  First year of life after the use of atenolol in pregnancy associated hypertension. , 1984, Archives of disease in childhood.

[21]  P. Rebulla Platelet transfusion trigger in difficult patients. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[22]  C. Callander,et al.  Coagulation screening before epidural analgesia in pre‐eclampsia , 1991, Anaesthesia.

[23]  S. Kaur,et al.  Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000 g. , 2008, American journal of obstetrics and gynecology.

[24]  N. Marlow,et al.  Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy , 2007, BMC Health Services Research.

[25]  U. Hanson,et al.  Epidemiology of pregnancy‐induced hypertension and preeclampsia in Type 1 (insulin‐dependent) diabetic pregnancies in Sweden , 1998, Acta obstetricia et gynecologica Scandinavica.

[26]  S. Heinonen,et al.  OBSTETRIC PROGNOSIS IN SECOND PREGNANCY AFTER PREECLAMPSIA IN FIRST PREGNANCY , 2000, Hypertension in pregnancy.

[27]  Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic Hypertension , 1998 .

[28]  R. Resnik,et al.  Evaluation of the use of continuous lumbar epidural anesthesia for hypertensive pregnant women in labor. , 1985, American journal of obstetrics and gynecology.

[29]  B. Sibai,et al.  Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. , 2007, American journal of obstetrics and gynecology.

[30]  Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.

[31]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[32]  F. Althabe,et al.  Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. , 2002, The Cochrane database of systematic reviews.

[33]  R. Kakuma,et al.  Energy and protein intake in pregnancy. , 2003, The Cochrane database of systematic reviews.

[34]  G. Espinosa,et al.  Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. , 2010, Autoimmunity reviews.

[35]  I. Russell,et al.  Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial , 2005, BMJ : British Medical Journal.

[36]  D. Chou,et al.  Magnesium sulphate versus diazepam for eclampsia. , 2010, The Cochrane database of systematic reviews.

[37]  B. Sibai,et al.  Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. , 1994, American journal of obstetrics and gynecology.

[38]  B. Young,et al.  Effects of Magnesium Sulfate on Toxemic Patients in Labor , 1977, Obstetrics and gynecology.

[39]  G. Bonsel,et al.  One‐year infant outcome in women with early‐onset hypertensive disorders of pregnancy , 2007, BJOG : an international journal of obstetrics and gynaecology.

[40]  R. Greene,et al.  Does increased resistance on umbilical artery Doppler preclude a trial of labour? , 1998, European journal of obstetrics, gynecology, and reproductive biology.

[41]  K. Leveno,et al.  Outpatient management of mild pregnancy induced hypertension , 1995 .

[42]  S. Yeo A randomized comparative trial of the efficacy and safety of exercise during pregnancy: design and methods. , 2006, Contemporary clinical trials.

[43]  P. Gartside,et al.  Prenatal Screening for Anticardiolipin Antibody , 1990, American journal of perinatology.

[44]  B. Sibai,et al.  Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. , 1992, American journal of obstetrics and gynecology.

[45]  W. Fetter,et al.  A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre‐eclampsia , 2005, BJOG : an international journal of obstetrics and gynaecology.

[46]  M. Lindheimer,et al.  Explaining and predicting preeclampsia. , 2006, The New England journal of medicine.

[47]  T. Dowswell,et al.  Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. , 2010, The Cochrane database of systematic reviews.

[48]  M. Torloni,et al.  Does sodium nitroprusside kill babies? A systematic review. , 2007, Sao Paulo medical journal = Revista paulista de medicina.

[49]  Mervi Jokinen,et al.  The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community , 2005, BMJ : British Medical Journal.

[50]  P. Morgan The Effect of Increasing Central Blood Volume to Decrease the Incidence of Hypotension Following Spinal Anesthesia for Cesarean Section , 2007 .

[51]  S. Matsubara,et al.  Recurrence Risk of Preterm Birth due to Preeclampsia , 2002, Gynecologic and Obstetric Investigation.

[52]  A. Ulloa-Aguirre,et al.  Protein:creatinine ratio in random urine samples is a reliable marker of increased 24-hour protein excretion in hospitalized women with hypertensive disorders of pregnancy. , 2007, Clinical chemistry.

[53]  S. Campbell,et al.  The role of color Doppler imaging of the uterine arteries at 20 weeks' gestation in stratifying antenatal care , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[54]  K. Palmer,et al.  Risk of prematurity, low birthweight and pre-eclampsia in relation to working hours and physical activities: a systematic review , 2006, Occupational and Environmental Medicine.

[55]  Lawrence A Leiter,et al.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. , 2006, The Canadian journal of cardiology.

[56]  J. Pell,et al.  Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. , 2004, American journal of epidemiology.

[57]  F. Audibert,et al.  Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. , 2010, American journal of obstetrics and gynecology.

[58]  D. Chestnut,et al.  A Randomized Trial of Intrapartum Analgesia in Women With Severe Preeclampsia , 2002, Obstetrics and gynecology.

[59]  M. Kilby,et al.  Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy , 2005, BJOG : an international journal of obstetrics and gynaecology.

[60]  B. Mercer,et al.  A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia. , 2003, American journal of obstetrics and gynecology.

[61]  D. Mathews,et al.  A randomized controlled trial of complete bed rest versus ambulation in the management of proteinuric hypertension during pregnancy , 1982, British journal of obstetrics and gynaecology.

[62]  A. Logan,et al.  A Survey of Canadian Practitioners Regarding the Management of the Hypertensive Disorders of Pregnancy , 2004, Hypertension in pregnancy.

[63]  D. Rocke,et al.  Rapidly progressive laryngeal oedema associated with pregnancy‐aggravated hypertension , 1992, Anaesthesia.

[64]  A. Makris,et al.  Postpartum hypertension and nonsteroidal analgesia. , 2004, American journal of obstetrics and gynecology.

[65]  R. A. Young,et al.  Use of the protein/creatinine ratio of a single voided urine specimen in the evaluation of suspected pregnancy-induced hypertension. , 1996, The Journal of family practice.

[66]  D. Turnbull,et al.  Antenatal day care units versus hospital admission for women with complicated pregnancy. , 2001, The Cochrane database of systematic reviews.

[67]  B Waeber,et al.  European Society of Hypertension Practice Guidelines for home blood pressure monitoring , 2010, Journal of Human Hypertension.

[68]  K. Harrington,et al.  Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. , 1999, American journal of obstetrics and gynecology.

[69]  C. Redman,et al.  FINAL REPORT OF STUDY ON HYPERTENSION DURING PREGNANCY: THE EFFECTS OF SPECIFIC TREATMENT ON THE GROWTH AND DEVELOPMENT OF THE CHILDREN , 1982, The Lancet.

[70]  B. Duncan,et al.  Aerobic Exercise and Submaximal Functional Capacity in Overweight Pregnant Women: A Randomized Trial , 2005, Obstetrics and gynecology.

[71]  R. Lilford,et al.  Randomised controlled trial of day care for hypertension in pregnancy , 1992, The Lancet.

[72]  B. Carvalho,et al.  Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs. , 2010, International journal of obstetric anesthesia.

[73]  A. Baschat Pathophysiology of Fetal Growth Restriction: Implications for Diagnosis and Surveillance , 2004, Obstetrical & gynecological survey.

[74]  M. Merialdi,et al.  Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre‐eclampsia and eclampsia , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[75]  J. Ray,et al.  MOS HIP: McMaster outcome study of hypertension in pregnancy. , 2001, Early human development.

[76]  W. Mroczek,et al.  Effect of magnesium sulfate on cardiovascular hemodynamics. , 1978, Angiology.

[77]  A. van Wassenaer,et al.  No association between maternal psychological symptoms and infant outcome after pregnancy complicated by early‐onset hypertensive disorders , 2009, Acta paediatrica.

[78]  P. Vigil-De Gracia,et al.  Anesthesia in pregnant women with HELLP syndrome , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[79]  A. Hollmen,et al.  Lumbar Epidural Analgesia to Improve Intervillous Blood Flow During Labor in Severe Preeclampsia , 1982, Obstetrics and gynecology.

[80]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[81]  D. Li,et al.  Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. , 2000, American journal of epidemiology.

[82]  R. Olszanecki,et al.  Effects of prolonged oral supplementation with l‐arginine on blood pressure and nitric oxide synthesis in preeclampsia , 2005, European journal of clinical investigation.

[83]  B. Sibai,et al.  Monitored outpatient management of mild gestational hypertension remote from term. , 1994, American journal of obstetrics and gynecology.

[84]  S. Rabkin,et al.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[85]  R. Hamlin The prevention of eclampsia and pre-eclampsia. , 1952, Lancet.

[86]  L. Poston,et al.  A longitudinal study of biochemical variables in women at risk of preeclampsia. , 2002, American journal of obstetrics and gynecology.

[87]  P. Magnus,et al.  Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia. , 2001, International journal of epidemiology.

[88]  T. McElrath,et al.  The use of central neuraxial techniques in parturients with factor V leiden mutation. , 2005, Anesthesia and analgesia.

[89]  F. Viteri,et al.  Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. , 2006, The Cochrane database of systematic reviews.

[90]  N. Mosaffa,et al.  Random urine protein to creatinine ratio as a diagnostic method of significant proteinuria in pre‐eclampsia , 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

[91]  P. Chamberlain,et al.  Ultrasound evaluation of amniotic fluid volume. I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. , 1984, American journal of obstetrics and gynecology.

[92]  K. Law,et al.  Is in-patient management of diastolic blood pressure between 90 and 100 mm Hg during pregnancy necessary? , 1998, Hong Kong medical journal = Xianggang yi xue za zhi.

[93]  S. Gange,et al.  Physical and psychosocial side effects of antepartum hospital bed rest. , 1993, Nursing research.

[94]  C. Rhodes,et al.  Diuretics for preventing pre-eclampsia. , 2007, The Cochrane database of systematic reviews.

[95]  B. Sibai,et al.  Mild gestational hypertension remote from term: progression and outcome. , 2001, American journal of obstetrics and gynecology.

[96]  A. Shennan,et al.  An accurate automated blood pressure device for use in pregnancy and pre‐eclampsia: the Microlife 3BTO‐A , 2005, BJOG : an international journal of obstetrics and gynaecology.

[97]  K. Mahomed Zinc supplementation in pregnancy. , 1997, The Cochrane database of systematic reviews.

[98]  G. Lip,et al.  Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups. , 1998, QJM : monthly journal of the Association of Physicians.

[99]  Caroline A Crowther,et al.  Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study , 2006, BMJ : British Medical Journal.

[100]  Á. Atallah,et al.  Dietary calcium supplementation for prevention of pre‐eclampsia and related problems: a systematic review and commentary , 2007, BJOG : an international journal of obstetrics and gynaecology.

[101]  Trina Stryker,et al.  Accuracy of home blood pressure readings: monitors and operators , 2004, Blood pressure monitoring.

[102]  A. Gul,et al.  Maternal and Fetal Outcomes in HELLP Syndrome Complicated with Acute Renal Failure , 2004, Renal failure.

[103]  I. Greer,et al.  Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. , 2005, Blood.

[104]  B. Sibai,et al.  Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. , 2007, American journal of obstetrics and gynecology.

[105]  L. Duley,et al.  Magnesium sulphate versus lytic cocktail for eclampsia. , 2001, The Cochrane database of systematic reviews.

[106]  J. Brimacombe Acute Pharyngolaryngeal Oedema and Pre-Eclamptic Toxaemia , 1992, Anaesthesia and intensive care.

[107]  E. Burgess,et al.  Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[108]  F. Gelal,et al.  Cranial MR imaging with clinical correlation in preeclampsia and eclampsia. , 2005, Diagnostic and interventional radiology.

[109]  A. Shennan,et al.  Inpatient Monitoring on an Outpatient Basis: Managing Hypertensive Pregnancies in the Community Using Automated Technologies , 2001, The Journal of the Society for Gynecologic Investigation: JSGI.

[110]  L. Horwood,et al.  Comparison of methods to identify significant proteinuria in pregnancy in the outpatient setting , 2008, BJOG : an international journal of obstetrics and gynaecology.

[111]  B. Sibai,et al.  Pitfalls in diagnosis and management of preeclampsia. , 1988, American journal of obstetrics and gynecology.

[112]  R. Collins,et al.  Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre‐eclampsia and its complications , 1998, British journal of obstetrics and gynaecology.

[113]  G. Lip,et al.  Effect of atenolol on birth weight. , 1997, The American journal of cardiology.

[114]  Michael B Bracken,et al.  Work, leisure-time physical activity, and risk of preeclampsia and gestational hypertension. , 2004, American journal of epidemiology.

[115]  Geoffrey A Head,et al.  Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study , 2010, BMJ : British Medical Journal.

[116]  R. Ness,et al.  Periconceptional multivitamin use reduces the risk of preeclampsia. , 2006, American journal of epidemiology.

[117]  H. Nisell,et al.  Urine albumin/creatinine ratio for the assessment of albuminuria in pregnancy hypertension , 2006, Acta obstetricia et gynecologica Scandinavica.

[118]  Mark A. Klebanoff,et al.  Aspirin Use and Miscarriage Risk , 2006, Epidemiology.

[119]  B. Uerpairojkit,et al.  Correlation between random urinary protein-to-creatinine ratio and quantitation of 24-hour proteinuria in preeclampsia. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[120]  A. Ebrashy,et al.  Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. , 2005, Croatian medical journal.

[121]  J. Higgins,et al.  The detection, investigation and management of hypertension in pregnancy: executive summary , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.

[122]  B. Gutsche,et al.  Maternal Catecholamines Decrease During Labor After Lumbar Epidural Anesthesia , 1983, American journal of obstetrics and gynecology.

[123]  T. Laskowska-Klita,et al.  [Effect of vitamin-mineral supplementation on the status of some microelements in pregnant women]. , 2004, Przeglad lekarski.

[124]  G. Prescott,et al.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study , 2003, BMJ : British Medical Journal.

[125]  D. Chou,et al.  Magnesium sulphate versus phenytoin for eclampsia. , 2010, The Cochrane database of systematic reviews.

[126]  D. Damron Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension. , 2007, Obstetrics and gynecology.

[127]  C. van Walraven,et al.  Risk of subsequent thromboembolism for patients with pre-eclampsia , 2003, BMJ : British Medical Journal.

[128]  M. de Swiet,et al.  The management of postpartum hypertension , 2002, BJOG : an international journal of obstetrics and gynaecology.

[129]  M. Olovsson,et al.  Random albumin/creatinine ratio for quantification of proteinuria in manifest pre‐eclampsia , 2006 .

[130]  S. Bottoms,et al.  Underappreciated risks of the elderly multipara. , 1995, American journal of obstetrics and gynecology.

[131]  B. Sibai,et al.  The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. , 1988, American journal of obstetrics and gynecology.

[132]  B. Sibai,et al.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. , 2006, The New England journal of medicine.

[133]  Kortaro Tanaka,et al.  Recovery of decreased local cerebral blood flow detected by the xenon/CT CBF method in a patient with eclampsia. , 2000, The Keio journal of medicine.

[134]  F. Malone,et al.  Quad Screen as a Predictor of Adverse Pregnancy Outcome , 2005, Obstetrics and gynecology.

[135]  A. Wakeley,et al.  Mode of delivery in pregnancies complicated by preeclampsia with very low birth weight infants. , 1995, Journal of perinatology : official journal of the California Perinatal Association.

[136]  J. Polak,et al.  Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. , 2000, Radiology.

[137]  R. Bagga,et al.  Pregnancy Complicated by Severe Chronic Hypertension: A 10-Year Analysis from a Developing Country , 2007, Hypertension in pregnancy.

[138]  R. Silver,et al.  Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? , 2007, Current rheumatology reports.

[139]  M. Leeflang,et al.  Are tests for predicting pre‐eclampsia good enough to make screening viable? A review of reviews and critical appraisal , 2009, Acta obstetricia et gynecologica Scandinavica.

[140]  B. Sibai,et al.  Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. , 1991, Anesthesia and analgesia.

[141]  LJ Muglia,et al.  Association of early‐onset pre‐eclampsia in first pregnancy with normotensive second pregnancy outcomes: a population‐based study , 2010, BJOG : an international journal of obstetrics and gynaecology.

[142]  R. Hermida,et al.  Circadian Rhythm of Blood Pressure Challenges Office Values as the “Gold Standard” in the Diagnosis of Gestational Hypertension , 2003, Chronobiology international.

[143]  S. Batra,et al.  Calcium supplementation for the prevention of pre‐eclampsia , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[144]  A. Jacoby,et al.  Women's experiences of participating in the Magpie Trial: a postal survey in the United Kingdom. , 2009, Birth.

[145]  G. Ryan,et al.  Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. , 1986, American journal of obstetrics and gynecology.

[146]  J. Vermylen,et al.  Anticoagulants and Spinal‐Epidural Anesthesia , 1994, Anesthesia and analgesia.

[147]  K. Offord,et al.  Does Preoperative Antiplatelet Therapy Increase the Risk of Hemorrhagic Complications Associated With Regional Anesthesia? , 1990, Anesthesia and analgesia.

[148]  A. Gülmezoglu,et al.  Anticonvulsants for women with pre-eclampsia. , 2000, The Cochrane database of systematic reviews.

[149]  A. Lalonde,et al.  Active management of the third stage of labour: Prevention and treatment of postpartum hemorrhage , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[150]  L. Chesley Eclampsia: the remote prognosis. , 1978, Seminars in perinatology.

[151]  R. Ness,et al.  Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension , 2005, Hypertension.

[152]  G. Saade,et al.  Vitamins C and E to prevent complications of pregnancy-associated hypertension. , 2010, The New England journal of medicine.

[153]  Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1999, The New England journal of medicine.

[154]  I. Adams-Chapman Neurodevelopmental outcome of the late preterm infant. , 2006, Clinics in perinatology.

[155]  H. Gerstein,et al.  Kidney disease after preeclampsia: a systematic review and meta-analysis. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[156]  M. Brown,et al.  Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy. , 2002, American journal of obstetrics and gynecology.

[157]  T. Cole,et al.  Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake123 , 2010, The American journal of clinical nutrition.

[158]  Y. Batra,et al.  Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancy-induced hypertension , 1993, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[159]  H. Saconato,et al.  Oral drugs for hypertensive urgencies: systematic review and meta-analysis. , 2009, Sao Paulo medical journal = Revista paulista de medicina.

[160]  D. Grové,et al.  Aggressive or Expectant Management for Patients With Severe Preeclampsia Between 28–34 Weeks' Gestation: A Randomized Controlled Trial , 1990, Obstetrics and gynecology.

[161]  D. Kallogjeri,et al.  Recurrence of Preeclampsia: Effects of Gestational Age at Delivery of the First Pregnancy, Body Mass Index, Paternity, and Interval Between Births , 2009 .

[162]  R. Frydman,et al.  Prediction of Preeclampsia or Intrauterine Growth Restriction by Second Trimester Serum Screening and Uterine Doppler Velocimetry , 2004, Fetal Diagnosis and Therapy.

[163]  L. Magee,et al.  The 24-hour urine collection: gold standard or historical practice? , 2008, American journal of obstetrics and gynecology.

[164]  A. Franx,et al.  Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial , 2009, The Lancet.

[165]  A. Skrondal,et al.  Recurrence risk of preeclampsia in twin and singleton pregnancies , 2004, American journal of medical genetics. Part A.

[166]  G. Dhall,et al.  A Safer and More Effective Treatment Regimen for Eclampsia , 1994, The Australian & New Zealand journal of obstetrics & gynaecology.

[167]  K. Arheart,et al.  Combined Spinal and Epidural Anesthesia With Low Doses of Intrathecal Bupivacaine in Women With Severe Preeclampsia: A Preliminary Report , 2000, Regional Anesthesia & Pain Medicine.

[168]  A. Sekizawa,et al.  Lower Rate of Preeclampsia After Antioxidant Supplementation in Pregnant Women with Low Antioxidant Status , 2006, Hypertension in pregnancy.

[169]  D. Steinberg,et al.  The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. , 2004, American journal of obstetrics and gynecology.

[170]  G. Saade,et al.  Vitamin C and E Supplementation to Prevent Spontaneous Preterm Birth: A Randomized Controlled Trial , 2010, Obstetrics and Gynecology.

[171]  R. North,et al.  Evaluation of Ambulatory and Self-Initiated Blood Pressure Monitors by Pregnant and Postpartum Women , 2001, Hypertension in pregnancy.

[172]  R. Frydman,et al.  Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. , 2003, American journal of obstetrics and gynecology.

[173]  C. Homer,et al.  The natural history of white coat hypertension during pregnancy , 2005, BJOG : an international journal of obstetrics and gynaecology.

[174]  K. Hecher,et al.  Fetal growth restriction due to placental disease. , 2004, Seminars in perinatology.

[175]  F. Pipkin,et al.  Predicting high blood pressure in pregnancy: a multivariate approach , 1998, Journal of hypertension.

[176]  A. Calle,et al.  Coenzyme Q10 supplementation during pregnancy reduces the risk of pre‐eclampsia , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[177]  Z. Bhutta,et al.  Pyridoxine (vitamin B6) supplementation in pregnancy. , 2006, The Cochrane database of systematic reviews.

[178]  R. Moss‐Morris,et al.  Risk factors for small‐for‐gestational‐age infants by customised birthweight centiles: data from an international prospective cohort study , 2010, BJOG : an international journal of obstetrics and gynaecology.

[179]  E. Wallace,et al.  Effect of antenatal betamethasone administration on placental vascular resistance , 1999, The Lancet.

[180]  K A Douglas,et al.  Eclampsia in the United Kingdom , 1994, BMJ.

[181]  E. Weiss,et al.  Condition at birth of infants with previously absent or reverse umbilical artery end-diastolic flow velocities , 2006, Archives of Gynecology and Obstetrics.

[182]  M. Bracken Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors , 2007 .

[183]  A. Dembińska-kieć,et al.  Effects of oral L-arginine on the pulsatility indices of umbilical artery and middle cerebral artery in preterm labor. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[184]  M. Lindheimer,et al.  World Health Organization Systematic Review of Screening Tests for Preeclampsia , 2004, Obstetrics and gynecology.

[185]  S. Karumanchi,et al.  CHAPTER 42 – Renal Complications in Normal Pregnancy , 2010 .

[186]  L. Magee,et al.  Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis , 2003, BMJ : British Medical Journal.

[187]  T. Weber,et al.  Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil , 2007, European Journal of Clinical Nutrition.

[188]  J. Moutquin,et al.  Low-dose ASA response using the PFA-100 in women with high-risk pregnancy. , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[189]  H. Augustin,et al.  Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia , 2004, Hypertension in pregnancy.

[190]  S. Hernández-Díaz,et al.  Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study , 2009, BMJ : British Medical Journal.

[191]  L. Shulman Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor , 2008 .

[192]  G. Macones,et al.  Antiphospholipid Antibodies in Chronic Hypertension: The Value of Screening During Pregnancy , 1998, American journal of perinatology.

[193]  F. Abroug,et al.  Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol , 2002, Intensive Care Medicine.

[194]  G. ter Riet,et al.  Accuracy of serum uric acid determination in predicting pre‐eclampsia: A systematic review , 2006, Acta obstetricia et gynecologica Scandinavica.

[195]  B. Vásárhelyi,et al.  Family history of early-onset cardiovascular disorders is associated with a higher risk of severe preeclampsia. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[196]  E. Crosby,et al.  Obstetrical anaesthesia for a parturient with preeclampsia, HELLP syndrome and acute cortical blindness , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[197]  R. Sherwin,et al.  Maternal ketosis and its effects on the fetus. , 1983, Clinics in endocrinology and metabolism.

[198]  C. Bodian,et al.  Practice Patterns of Anesthesiologists Regarding Situations in Obstetric Anesthesia Where Clinical Management Is Controversial , 1996, Anesthesia and analgesia.

[199]  P. Chamberlain,et al.  Ultrasound evaluation of amniotic fluid volume. II. The relationship of increased amniotic fluid volume to perinatal outcome. , 1984, American journal of obstetrics and gynecology.

[200]  J. Singer,et al.  The Control of Hypertension In Pregnancy Study pilot trial , 2007, BJOG : an international journal of obstetrics and gynaecology.

[201]  Lelia Duley,et al.  Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.

[202]  K. Khan,et al.  Accuracy of Urinalysis Dipstick Techniques in Predicting Significant Proteinuria in Pregnancy , 2004, Obstetrics and gynecology.

[203]  C. Redman,et al.  Maternal hypertension with superimposed pre‐eclampsia: effects on child development at 7½ years , 1983, British journal of obstetrics and gynaecology.

[204]  J. Sundsfjord,et al.  A study on oedema mechanism in nephrotic syndrome. , 1986, Scandinavian journal of clinical and laboratory investigation.

[205]  Aeilko H. Zwinderman,et al.  Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis , 2008, Canadian Medical Association Journal.

[206]  G. Koren,et al.  Neurocognitive Development of Children Following In-Utero Exposure to Labetalol for Maternal Hypertension: A Cohort Study Using a Prospectively Collected Database , 2010, Hypertension in pregnancy.

[207]  J. Martin,et al.  Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure , 2005, Obstetrics and gynecology.

[208]  M. Walker,et al.  Heparin for pregnant women with acquired or inherited thrombophilias. , 2003, The Cochrane database of systematic reviews.

[209]  T. N. Abdella,et al.  Pregnancy Outcome in 211 Patients With Mild Chronic Hypertension , 1983, Obstetrics and Gynecology.

[210]  E. Rey,et al.  Home Blood Pressure Levels in Pregnant Women with Chronic Hypertension , 2007, Hypertension in pregnancy.

[211]  S. Cnattingius,et al.  Preterm and term births of small for gestational age infants: a population‐based study of risk factors among nulliparous women , 1998, British journal of obstetrics and gynaecology.

[212]  K. Haram,et al.  Serum Urate as a Predictor of Fetal Outcome in Severe Pre‐Eclampsia , 1984, Acta obstetricia et gynecologica Scandinavica.

[213]  J. Brisson,et al.  The effect of leisure time physical activity on the risk of pre-eclampsia and gestational hypertension. , 1989, Journal of epidemiology and community health.

[214]  J. Villar,et al.  The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis. , 1980, The American journal of clinical nutrition.

[215]  L. Magee,et al.  Oral beta-blockers for mild to moderate hypertension during pregnancy. , 2000, The Cochrane database of systematic reviews.

[216]  R. Niederman Periodontal treatment did not prevent complications of pregnancy , 2010, Evidence-Based Dentistry.

[217]  Á. Atallah,et al.  Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. , 2002, The Cochrane database of systematic reviews.

[218]  G. H. Lambert,et al.  Transfer of drugs and other chemicals into human milk. , 2001, Pediatrics.

[219]  A. Caruso,et al.  Proteinuria and outcome of 444 pregnancies complicated by hypertension. , 1990, American journal of obstetrics and gynecology.

[220]  D. Subtil,et al.  Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. , 2006, European journal of obstetrics, gynecology, and reproductive biology.

[221]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[222]  A. Baschat,et al.  Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed? , 2003, Current opinion in obstetrics & gynecology.

[223]  B. Branger,et al.  L-Arginine treatment for severe vascular fetal intrauterine growth restriction: a randomized double-bind controlled trial. , 2009, Clinical nutrition.

[224]  F. Malone,et al.  First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). , 2004, American journal of obstetrics and gynecology.

[225]  J. Roberts,et al.  Recent Insights into the pathogenesis of pre-eclampsia. , 2002, Placenta.

[226]  P. Devos,et al.  Immediate and delayed effects of antenatal corticosteroids on fetal heart rate: a randomized trial that compares betamethasone acetate and phosphate, betamethasone phosphate, and dexamethasone. , 2003, American journal of obstetrics and gynecology.

[227]  M. Thompson,et al.  Recreational Physical Activity During Pregnancy and Risk of Preeclampsia , 2003, Hypertension.

[228]  L. Duley,et al.  Garlic for preventing pre-eclampsia and its complications. , 2006, The Cochrane database of systematic reviews.

[229]  T. Hulsey,et al.  Differences in Black and White Infant Birth Weights: The Role of Maternal Demographic Factors and Medical Complications of Pregnancy , 1991, Southern medical journal.

[230]  L. Poston,et al.  British Hypertension Society guidelines for hypertension management 1999: summary , 1999, BMJ.

[231]  J. Barton,et al.  Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. , 2006, Disease management : DM.

[232]  E. Rey,et al.  Blood Pressure Assessments in Different Subtypes of Hypertensive Pregnant Women: Office Versus Home Patient- or Nurse-Measured Blood Pressure , 2009, Hypertension in pregnancy.

[233]  E. A. Friedman,et al.  Pregnancy, outcome as related to hypertension, edema, and proteinuria. , 1976, Perspectives in nephrology and hypertension.

[234]  A. Coomarasamy,et al.  Accuracy of serum uric acid in predicting complications of pre‐eclampsia: a systematic review , 2006, BJOG : an international journal of obstetrics and gynaecology.

[235]  L. Magee,et al.  Maternal Hypertension and Neonatal Outcome Among Small for Gestational Age Infants , 2005, Obstetrics and gynecology.

[236]  P. Sandset,et al.  Ante‐ and postnatal risk factors of venous thrombosis: a hospital‐based case–control study , 2008, Journal of thrombosis and haemostasis : JTH.

[237]  R. D. Manning,et al.  Effects of hypoproteinemia on fluid volumes and arterial pressure. , 1983, The American journal of physiology.

[238]  K. Christensen,et al.  Higher risk of pre-eclampsia after change of partner. An effect of longer interpregnancy intervals? , 2001, Epidemiology.

[239]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[240]  Carole Rudra,et al.  Perceived exertion during prepregnancy physical activity and preeclampsia risk. , 2005, Medicine and science in sports and exercise.

[241]  G. Rydén,et al.  The Influence of Different Positions and Korotkoff Sounds on the Blood Pressure Measurements in Pregnancy , 1984, Acta obstetricia et gynecologica Scandinavica. Supplement.

[242]  I. Tasha,et al.  The value of the middle cerebral to umbilical artery Doppler ratio in the prediction of neonatal outcome in patient with preeclampsia and gestational hypertension. , 2010, Journal of prenatal medicine.

[243]  L. Magee,et al.  The prediction of adverse maternal outcomes in preeclampsia. , 2004, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[244]  K. Nasu,et al.  Low-dose dopamine in treating acute renal failure caused by preeclampsia. , 1996, Gynecologic and obstetric investigation.

[245]  B. Sibai,et al.  Safety of labor epidural anesthesia for women with severe hypertensive disease. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1999, American journal of obstetrics and gynecology.

[246]  J. F. Hernández-Sierra,et al.  EFFICACY OF NITROGLYCERINE INFUSION VERSUS SUBLINGUAL NIFEDIPINE IN SEVERE PRE‐ECLAMPSIA: A RANDOMIZED, TRIPLE‐BLIND, CONTROLLED TRIAL , 2008, Clinical and experimental pharmacology & physiology.

[247]  L. Poston,et al.  Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.

[248]  A. Bérard,et al.  Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension. , 2009, American journal of obstetrics and gynecology.

[249]  Jennifer G. Lyons,et al.  Protein:creatinine ratio in uncomplicated twin pregnancy. , 2010, American journal of obstetrics and gynecology.

[250]  T. Leet,et al.  Preeclampsia in the parous woman: who is at risk? , 2002, American journal of obstetrics and gynecology.

[251]  V. Steinthorsdottir,et al.  Recurrence of hypertensive disorder in second pregnancy. , 2006, American journal of obstetrics and gynecology.

[252]  R. Ruano,et al.  Prevention of preeclampsia with low-dose aspirin -- a systematic review and meta-analysis of the main randomized controlled trials. , 2005, Clinics.

[253]  J. Kingdom,et al.  Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. , 2006, American journal of obstetrics and gynecology.

[254]  M. Prins,et al.  Simple Prepregnant Prediction Rule for Recurrent Early-onset Hypertensive Disease in Pregnancy , 2009, Reproductive Sciences.

[255]  P. Olofsson,et al.  Prospect for vaginal delivery of growth restricted fetuses with abnormal umbilical artery blood flow. , 2004, Acta obstetricia et gynecologica Scandinavica.

[256]  M. Buddie,et al.  The Importance of Nonproteinuric Hypertension in Pregnancy , 1995 .

[257]  A. Nabhan,et al.  A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy , 2008, Journal of perinatal medicine.

[258]  E. Greimel,et al.  Quality of life outcomes in pregnancy and postpartum complicated by hypertensive disorders, gestational diabetes, and preterm birth , 2009, Journal of psychosomatic obstetrics and gynaecology.

[259]  F. Légaré,et al.  Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. , 2010, Clinical chemistry.

[260]  L. Magee,et al.  An international trial of antioxidants in the prevention of preeclampsia (INTAPP). , 2010, American journal of obstetrics and gynecology.

[261]  G. Stamp,et al.  The psychosocial outcomes of antenatal day care for three medical complications of pregnancy: A randomised controlled trial of 395 women , 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

[262]  Y. Herabutya,et al.  The use of low‐dose aspirin to prevent preeclampsia , 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[263]  S. Kılıc,et al.  Predictive value of middle cerebral artery to uterine artery pulsatility index ratio in preeclampsia , 2011, Archives of Gynecology and Obstetrics.

[264]  R. North,et al.  Perinatal morbidity in chronic hypertension , 1996, British journal of obstetrics and gynaecology.

[265]  P. Box Hyperhomocysteinemia, pregnancy complications, and the timing of investigation , 2005 .

[266]  F. Wolf,et al.  WORKING CONDITIONS AND ADVERSE PREGNANCY OUTCOME: A META‐ANALYSIS , 2000, Obstetrics and gynecology.

[267]  G. Bonsel,et al.  A randomized trial of plasma volume expansion in hypertensive disorders of pregnancy: influence on the pulsatility indices of the fetal umbilical artery and middle cerebral artery. , 2005, American journal of obstetrics and gynecology.

[268]  D. Henderson-smart,et al.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.

[269]  W. Fraser,et al.  Impact of preeclampsia and gestational hypertension on birth weight by gestational age. , 2002, American journal of epidemiology.

[270]  G. Lockitch Handbook of diagnostic biochemistry and hematology in normal pregnancy , 1993 .

[271]  H. Odendaal,et al.  Do women with pre-eclampsia and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial , 2002 .

[272]  D. Savitz,et al.  Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991 , 1995, Acta obstetricia et gynecologica Scandinavica.

[273]  L. Devoe,et al.  The effects of epidural anesthesia on the Doppler velocimetry of umbilical and uterine arteries in normal and hypertensive patients during active term labor , 1991, Obstetrics and gynecology.

[274]  G. Saade,et al.  L-Arginine Supplementation in Patients with Gestational Hypertension: A Pilot Study , 2007, Hypertension in pregnancy.

[275]  W. May,et al.  Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. , 2008, American journal of obstetrics and gynecology.

[276]  C. Antonakos,et al.  A Comparison of Walking versus Stretching Exercises to Reduce the Incidence of Preeclampsia: A Randomized Clinical Trial , 2008, Hypertension in pregnancy.

[277]  R. D. Manning,et al.  Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. , 1987, The American journal of physiology.

[278]  L. Magee,et al.  Prevention and treatment of postpartum hypertension. , 2005, The Cochrane database of systematic reviews.

[279]  M. Brown,et al.  Does gestational hypertension become pre‐eclampsia? , 1998, British journal of obstetrics and gynaecology.

[280]  C. Samama Should a normal thromboelastogram allow us to perform a neuraxial block? A strong word of warning , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[281]  T. Hulsey,et al.  Early-onset severe preeclampsia: induction of labor vs elective cesarean delivery and neonatal outcomes. , 2008, American journal of obstetrics and gynecology.

[282]  E. Lieberman,et al.  Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. , 2001, American journal of obstetrics and gynecology.

[283]  D. Wilkin,et al.  Induction of labour at term. Women not for waiting. , 1993, BMJ.

[284]  L. Poston,et al.  World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre‐eclampsia in populations of low nutritional status from developing countries , 2009, BJOG : an international journal of obstetrics and gynaecology.

[285]  M. Bots,et al.  Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. , 2006, American journal of obstetrics and gynecology.

[286]  I. Russell,et al.  Outcomes of severe pre‐eclampsia/eclampsia in Yorkshire 1999/2003 , 2005, BJOG : an international journal of obstetrics and gynaecology.

[287]  Joshua R. Smith,et al.  Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[288]  L. Magee,et al.  Expectant Management of Severe Preeclampsia Remote from Term: A Structured Systematic Review , 2009, Hypertension in pregnancy.

[289]  A. Vambergue,et al.  Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. , 2002, European journal of obstetrics, gynecology, and reproductive biology.

[290]  Z Alfirevic,et al.  Biophysical profile for fetal assessment in high risk pregnancies. , 2000, The Cochrane database of systematic reviews.

[291]  A. Testa,et al.  The duration of hypertension in the puerperium of preeclamptic women: relationship with renal impairment and week of delivery. , 1994, American journal of obstetrics and gynecology.

[292]  K. Kario,et al.  Masked Hypertension: A Review , 2007, Hypertension Research.

[293]  Y. Guérin,et al.  Urinary protein/creatinine ratio in hypertensive pregnant women. , 1999, Hypertension in pregnancy.

[294]  H. Ashurst,et al.  Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non‐proteinuric hypertension? , 1992 .

[295]  W. N. Ngan Kee,et al.  A Quantitative, Systematic Review of Randomized Controlled Trials of Ephedrine Versus Phenylephrine for the Management of Hypotension During Spinal Anesthesia for Cesarean Delivery , 2002, Anesthesia and analgesia.

[296]  J. Goudemand,et al.  Are Haemostatic and Fibrinolytic Parameters Predictors of Preeclampsia in Pregnancy-Associated Hypertension? , 1991, Thrombosis and Haemostasis.

[297]  J. Golding,et al.  A randomised trial of low dose aspirin for primiparae in pregnancy , 1998, British journal of obstetrics and gynaecology.

[298]  L. Poston,et al.  Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study , 2008, Hypertension.

[299]  U. Retzke,et al.  [Incidence of hypertension in pregnancy in relation to the definition of hypertension]. , 1994, Zentralblatt fur Gynakologie.

[300]  K. Savik,et al.  Bedrest compliance for women with pregnancy problems. , 1995, Birth.

[301]  Prevention and Management of Postpartum Haemorrhage , 2000 .

[302]  M. Kramer,et al.  Aerobic exercise for women during pregnancy. , 2006, The Cochrane database of systematic reviews.

[303]  G. Ferns,et al.  Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial. , 2010, Taiwanese journal of obstetrics & gynecology.

[304]  J. Singer,et al.  Women's Views of Their Experiences in the CHIPS (Control of Hypertension in Pregnancy Study) Pilot Trial , 2007, Hypertension in pregnancy.

[305]  J. Carcillo,et al.  Plasma Therapies in Thrombotic Syndromes , 2005, The International journal of artificial organs.

[306]  A. Trumble,et al.  Severe Maternal Morbidity Associated with Hypertensive Disorders in Pregnancy in the United States , 2003, Hypertension in pregnancy.

[307]  L. Wee,et al.  Central nerve block and coagulation: a survey of obstetric anaesthetists. , 2002, International journal of obstetric anesthesia.

[308]  C. Redman,et al.  Aspirin, extradural anaesthesia and the MRC Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) , 1992, British journal of anaesthesia.

[309]  C. Connolly,et al.  COMPARISON OF THE EFFICACY OF CONTINUOUS FUROSEMIDE AND LOW-DOSE DOPAMINE INFUSION IN PREECLAMPSIA/ECLAMPSIA-RELATED OLIGURIA IN THE IMMEDIATE POSTPARTUM PERIOD , 2002, Hypertension in pregnancy.

[310]  B. Carleton,et al.  Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. , 2005, American journal of obstetrics and gynecology.

[311]  K. Nicolaides,et al.  Prediction of pre‐eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[312]  T. Horlocker What’s a nice patient like you doing with a complication like this? Diagnosis, prognosis and prevention of spinal hematoma , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[313]  E. Rey,et al.  The prognosis of pregnancy in women with chronic hypertension. , 1994, American journal of obstetrics and gynecology.

[314]  L. Green,et al.  Managing anticoagulated patients during neuraxial anaesthesia , 2010, British journal of haematology.

[315]  S. Sidney,et al.  A multivariate analysis of risk factors for preeclampsia , 1992, JAMA.

[316]  M. Brown,et al.  Inadequacy of Dipstick Proteinuria in Hypertensive Pregnancy , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.

[317]  G. Cutter,et al.  Low‐dose aspirin therapy to prevent preeclampsia , 1994 .

[318]  Chan Jun-mi,et al.  International Consensus Statement on an Update of the Classification Criteria for Definite Antiphospholipid Syndrome(APS) , 2008 .

[319]  T. Einarson,et al.  Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. , 2006, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[320]  E. Gallery,et al.  EXCRETION OF ANTIHYPERTENSIVE MEDICATION INTO HUMAN BREAST MILK: A SYSTEMATIC REVIEW , 2002, Hypertension in pregnancy.

[321]  M. Helewa,et al.  Community-based home-care program for the management of pre-eclampsia: an alternative. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[322]  J. Clive,et al.  Elevated Second‐Trimester Maternal Serum hCG Alone or in Combination With Elevated Alpha‐Fetoprotein , 1996, Obstetrics and gynecology.

[323]  A. Logan,et al.  Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[324]  Ana Lúcia Letti Müller,et al.  Variation in the Urinary Protein/Creatinine Ratio at Four Different Periods of the Day in Hypertensive Pregnant Women , 2005, Hypertension in pregnancy.

[325]  J. Barton,et al.  Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. , 2002, American journal of obstetrics and gynecology.

[326]  E. Schiffrin,et al.  The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. , 2010, The Canadian journal of cardiology.

[327]  B. Sibai,et al.  Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. , 2002, American journal of obstetrics and gynecology.

[328]  V. Insler,et al.  Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol. , 1986, European journal of obstetrics, gynecology, and reproductive biology.

[329]  C. Crowther,et al.  Magnesium supplementation in pregnancy. , 2001, The Cochrane database of systematic reviews.

[330]  J. Bonnar,et al.  Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre‐eclampsia , 1994, British journal of obstetrics and gynaecology.

[331]  D. Young,et al.  Fetal health surveillance: antepartum and intrapartum consensus guideline. , 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[332]  L. Duley,et al.  Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. , 2006, The Cochrane database of systematic reviews.

[333]  P. Landsbergis,et al.  Psychosocial Work Stress and Pregnancy‐Induced Hypertension , 1996, Epidemiology.

[334]  L. A. Wolfe,et al.  Exercise in pregnancy and the postpartum period. , 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[335]  R. T. Lie,et al.  Fetal and maternal contributions to risk of pre-eclampsia: population based study , 1998, BMJ.

[336]  W. Grobman,et al.  Serum Levels of Activin A and Inhibin A and the Subsequent Development of Preeclampsia , 2000, Obstetrics and gynecology.

[337]  D. Henderson-smart,et al.  Altered dietary salt for preventing pre-eclampsia, and its complications. , 2005, The Cochrane database of systematic reviews.

[338]  F. Facchinetti,et al.  24-hour ambulatory blood pressure monitoring: a comparison between transdermal glyceryl-trinitrate and oral nifedipine. , 1999, Hypertension in pregnancy.

[339]  G. Koren,et al.  Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?* , 2002, Critical care medicine.

[340]  C. Rout,et al.  Effects of alfentanil and fentanyl on induction of anaesthesia in patients with severe pregnancy-induced hypertension. , 1990, British journal of anaesthesia.

[341]  M. Dramaix,et al.  Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. , 1997, American journal of epidemiology.

[342]  E. Abalos,et al.  Bed rest with or without hospitalisation for hypertension during pregnancy. , 2005, The Cochrane database of systematic reviews.

[343]  J N Martin,et al.  The natural history of HELLP syndrome: patterns of disease progression and regression. , 1991, American journal of obstetrics and gynecology.

[344]  A. Larsson,et al.  Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia , 2004, Scandinavian journal of clinical and laboratory investigation.

[345]  G. Bonsel,et al.  Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy. , 2007, American journal of obstetrics and gynecology.

[346]  B. Sibai,et al.  Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. , 1995, American journal of obstetrics and gynecology.

[347]  W Greg Miller,et al.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. , 2006, Clinical chemistry.

[348]  J. N. Martin,et al.  The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. , 1994, American journal of obstetrics and gynecology.

[349]  K. Joseph,et al.  The Effect of Hypertensive Disorders in Pregnancy on Perinatal Outcomes: A Population-Based Cohort Study , 2002 .

[350]  W. Rath,et al.  Psychosocial distress associated with treatment of hypertensive diseases in pregnancy. , 2008, Psychosomatics.

[351]  C. Baykal,et al.  Random Urine Protein-Creatinine Ratio to Predict Proteinuria in New-Onset Mild Hypertension in Late Pregnancy , 2004, Obstetrics and gynecology.

[352]  A. Hiett,et al.  Outcome of infants delivered between 24 and 28 weeks' gestation in women with severe pre-eclampsia , 2001, The Journal of maternal-fetal medicine.

[353]  B. Kestenbaum,et al.  Cardiovascular and thromboembolic events following hypertensive pregnancy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[354]  S. Montán,et al.  Randomised controlled trial of methyldopa and isradipine in preeclampsia – effects on uteroplacental and fetal hemodynamics , 1996, Journal of perinatal medicine.

[355]  I. Greer Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. , 1997, Bailliere's clinical obstetrics and gynaecology.

[356]  H. Lagercrantz,et al.  Neonatal adaptation in hypertensive pregnancy — A study of labetalol vs hydralazine treatment , 1993, Journal of perinatal medicine.

[357]  M. Swiet,et al.  Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry , 1996, The Lancet.

[358]  A. Griffiths,et al.  Induction to delivery time interval in patients with and without preeclampsia: a retrospective analysis , 2002, Acta obstetricia et gynecologica Scandinavica.

[359]  C. Best,et al.  The recurrence risk of severe de novo pre‐eclampsia in singleton pregnancies: a population‐based cohort , 2009, BJOG : an international journal of obstetrics and gynaecology.

[360]  B. Sibai,et al.  Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. , 2008, Obstetrics and gynecology.

[361]  J. Gandon,et al.  P-40: Home blood pressure measured telemetrically in hypertensive pregnant women , 2001 .

[362]  M. Makary,et al.  Impact of bariatric surgery on hypertensive disorders in pregnancy: retrospective analysis of insurance claims data , 2010, BMJ : British Medical Journal.

[363]  D. Taylor,et al.  Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension? , 1997, American journal of obstetrics and gynecology.

[364]  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. , 2000, American journal of obstetrics and gynecology.

[365]  A. Çeti̇n,et al.  The Effect of Glyceryl Trinitrate on Hypertension in Women with Severe Preeclampsia, HELLP Syndrome, and Eclampsia , 2004, Hypertension in pregnancy.

[366]  B. Sibai,et al.  Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.

[367]  H. Odendaal,et al.  Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial , 2000, BJOG : an international journal of obstetrics and gynaecology.

[368]  R. Gaiser,et al.  Circulating Angiogenic Factors and the Risk of Preeclampsia , 2005 .

[369]  C. Pieper,et al.  Job Stress and Preeclampsia , 1996, Epidemiology.

[370]  E. Schiffrin,et al.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. , 2006, The Canadian journal of cardiology.

[371]  A. Franx,et al.  An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre‐eclampsia at term (HYPITAT trial) , 2010, BJOG : an international journal of obstetrics and gynaecology.

[372]  François Audibert,et al.  Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.

[373]  W. Gilbert,et al.  Pregnancy outcomes in women with chronic hypertension: a population-based study. , 2007, The Journal of reproductive medicine.

[374]  J. Dommisse,et al.  Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy. , 1982, Clinical and experimental hypertension. Part B, Hypertension in pregnancy.

[375]  Xin Xiao,et al.  [Effect and mechanism of L-arginine therapy for fetal growth retardation due to pregnancy-induced hypertension]. , 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[376]  J. Kleijnen,et al.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. , 2008, BMC pregnancy and childbirth.

[377]  L. Duley,et al.  Exercise or other physical activity for preventing pre-eclampsia and its complications. , 2006, The Cochrane database of systematic reviews.

[378]  J. López,et al.  Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial. , 2006 .

[379]  G. Dildy,et al.  Very advanced maternal age: pregnancy after age 45. , 1996, American journal of obstetrics and gynecology.

[380]  R. Olszanecki,et al.  Effects of oral L-arginine on the foetal condition and neonatal outcome in preeclampsia: a preliminary report. , 2006, Basic & clinical pharmacology & toxicology.

[381]  A. Seidler,et al.  Antiplatelet agents for preventing pre-eclampsia and its complications. , 2007, The Cochrane database of systematic reviews.

[382]  M. Brown,et al.  Improved methods of assessing proteinuria in hypertensive pregnancy , 1997, British journal of obstetrics and gynaecology.

[383]  M. Kilby,et al.  Urine Protein Estimation in Hypertensive Pregnancy: Which Thresholds and Laboratory Assay Best Predict Clinical Outcome? , 2005, Hypertension in pregnancy.

[384]  David J. Williams Pregnancy: a stress test for life , 2003, Current opinion in obstetrics & gynecology.

[385]  I. Bernstein,et al.  Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. , 1995, American journal of obstetrics and gynecology.

[386]  G. Y. Wong,et al.  Preoperative Antiplatelet Therapy Does Not Increase the Risk of Spinal Hematoma Associated with Regional Anesthesia , 1995, Anesthesia and analgesia.

[387]  J. Moodley,et al.  Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study. , 1994, American journal of hypertension.

[388]  M. L. Buddle,et al.  Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V , 1998, The Lancet.

[389]  B. Sibai Imitators of Severe Preeclampsia , 2007, Obstetrics and gynecology.

[390]  P. Mannucci,et al.  Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. , 2003, Haematologica.

[391]  S. Lev,et al.  Effect of Betamethasone Administration on Fetal Heart Rate Tracing: A Blinded Longitudinal Study , 2005, Fetal Diagnosis and Therapy.

[392]  S. Leung,et al.  A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour , 2006, BJOG : an international journal of obstetrics and gynaecology.

[393]  R. Liston,et al.  Random Protein‐Creatinine Ratio for the Quantitation of Proteinuria in Pregnancy , 1997, Obstetrics and gynecology.

[394]  M. Lamyian,et al.  The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia. , 2001, European journal of obstetrics, gynecology, and reproductive biology.

[395]  L. Magee,et al.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. , 2002, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[396]  José Villar,et al.  World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. , 2006, American journal of obstetrics and gynecology.

[397]  D. Elbourne,et al.  The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor. , 1993, The Online journal of current clinical trials.

[398]  B. Sibai,et al.  Pregnancy outcome of intensive therapy in severe hypertension in first trimester , 1986, Obstetrics and gynecology.

[399]  G. Novelli,et al.  Early and Late Preeclampsia: Two Different Maternal Hemodynamic States in the Latent Phase of the Disease , 2008, Hypertension.

[400]  S. Greene,et al.  Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort , 2007, Diabetologia.

[401]  A. R. Reed,et al.  Hemodynamic Changes Associated With Spinal Anesthesia for Cesarean Delivery in Severe Preeclampsia , 2008 .

[402]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[403]  P. Damm,et al.  Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic Nephropathy , 2009, Diabetes Care.

[404]  J. López,et al.  Management of Severe Hypertension in the Postpartum Period with Intravenous Hydralazine or Labetalol: A Randomized Clinical Trial , 2007, Hypertension in pregnancy.

[405]  J. Pritchard The use of the magnesium ion in the management of eclamptogenic toxemias. , 1955, Surgery, gynecology & obstetrics.

[406]  J. Simpson,et al.  Proteinuria in pre‐eclampsia: how much matters? , 2005, BJOG : an international journal of obstetrics and gynaecology.

[407]  L. Brancazio,et al.  Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. , 1995, American journal of obstetrics and gynecology.

[408]  S. Brennecke,et al.  The effect of hospitalisation on ambulatory blood pressure in pregnancy , 2002, The Australian & New Zealand journal of obstetrics & gynaecology.

[409]  S. Alahuhta,et al.  Maternal and uteroplacental haemodynamic state in pre-eclamptic patients during spinal anaesthesia for Caesarean section. , 1996, British journal of anaesthesia.

[410]  K. Nicolaides,et al.  Pregnancy First-Trimester Prediction of Hypertensive Disorders in Pregnancy , 2009 .

[411]  R. Hermida,et al.  Prognostic Value of Office and Ambulatory Blood Pressure Measurements in Pregnancy , 2002, Hypertension.

[412]  Recurring Complications in Second Pregnancy , 2009, Obstetrics and gynecology.

[413]  B. Sibai,et al.  Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. , 1991, American journal of obstetrics and gynecology.

[414]  F. Bonilla-musoles,et al.  Ultrasound Markers of Fetal Infection Part 1: Viral Infections , 2005, Ultrasound quarterly.

[415]  Ji‐Hyung Park,et al.  A case of reversible postpartum cytotoxic edema in preeclampsia , 2004, Journal of the Neurological Sciences.

[416]  C. Redman,et al.  Hypertension during pregnancy, with and without specific hypotensive treatment. II. The growth and development of the infant in the first year of life. , 1977, Early human development.

[417]  J. Borensztajn,et al.  Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio. , 2002, American journal of obstetrics and gynecology.

[418]  C. Redman,et al.  The clinical utility of routine urinalysis in pregnancy , 2003, The Medical journal of Australia.

[419]  B. Gonik,et al.  Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. , 1984, American journal of obstetrics and gynecology.

[420]  J. Brichant,et al.  Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. , 2005, Acta anaesthesiologica Belgica.

[421]  D. Churchill,et al.  Fetal growth restriction , 2000, The Lancet.

[422]  M. Rönnback,et al.  Renal and vascular function in women with previous preeclampsia: a comparison of low- and high-degree proteinuria. , 2006, Kidney international.

[423]  W. Dunsmuir,et al.  Can we predict recurrence of pre‐eclampsia or gestational hypertension? , 2007, BJOG : an international journal of obstetrics and gynaecology.

[424]  L. Duley,et al.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. , 2010, The Cochrane database of systematic reviews.

[425]  L. Geerts,et al.  Severe early onset pre-eclampsia: prognostic value of ultrasound and Doppler assessment , 2007, Journal of Perinatology.

[426]  W. Leisenring,et al.  Dietary fiber, potassium, magnesium and calcium in relation to the risk of preeclampsia. , 2005, The Journal of reproductive medicine.

[427]  L. Magee,et al.  Do Commonly Used Oral Antihypertensives Alter Fetal or Neonatal Heart Rate Characteristics? A Systematic Review , 2004, Hypertension in pregnancy.

[428]  B. Sibai,et al.  Acute fatty liver of pregnancy in 3 tertiary care centers. , 2005, American journal of obstetrics and gynecology.

[429]  T. Bogard,et al.  The use of nitroglycerin in preventing the hypertensive response to tracheal intubation in severe preeclampsia. , 1986, Anesthesiology.

[430]  W. Lombardi,et al.  Wellness intervention with pregnant soldiers. , 1999, Military Medicine.

[431]  M. Habiba,et al.  Patient Initiated Home Blood Pressure Recordings Are Accurate in Hypertensive Pregnant Women , 2003, Hypertension in pregnancy.

[432]  J. Cutler,et al.  Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy , 2003, Hypertension in pregnancy.

[433]  J. Davison,et al.  Chronic kidney disease in pregnancy , 2008, BMJ : British Medical Journal.

[434]  E. Hook,et al.  The Association Between Maternal Serum Alpha‐Fetoprotein and Preterm Birth, Small for Gestational Age Infants, Preeclampsia, and Placental Complications , 1996, Obstetrics and gynecology.

[435]  B. Sibai,et al.  Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. , 2005, American journal of obstetrics and gynecology.

[436]  J. Piper,et al.  Preeclampsia: Is Induction of Labor More Successful? , 1997, Obstetrics and gynecology.

[437]  C. Michael Intravenous Labetalol and Intravenous Diazoxide in Severe Hypertension Complicating Pregnancy , 1986, The Australian & New Zealand journal of obstetrics & gynaecology.

[438]  M. Helewa,et al.  Patient satisfaction with an antepartum home-care program. , 1994, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[439]  M. López-Llera,et al.  Pregnancy after eclampsia. , 1974, American journal of obstetrics and gynecology.

[440]  R. Liston,et al.  Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review , 2008, BMJ : British Medical Journal.

[441]  S. Karumanchi,et al.  Angiogenic factors and preeclampsia. , 2007, Frontiers in bioscience : a journal and virtual library.

[442]  A. Shennan,et al.  Rapid Assessment of Blood Pressure in the Obstetric Day Unit Using Microlife MaM Technology , 2007, Hypertension in pregnancy.

[443]  S. Cnattingius,et al.  Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study , 2006, The Lancet.

[444]  John A. Heit,et al.  Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) , 2009, Regional Anesthesia & Pain Medicine.

[445]  H. Dinç,et al.  Comparison of cerebral magnetic resonance and electroencephalogram findings in pre‐eclamptic and eclamptic women , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[446]  T. Easterling,et al.  Treatment of Hypertension in Pregnancy: Effect of Atenolol on Maternal Disease, Preterm Delivery, and Fetal Growth , 2001, Obstetrics and gynecology.

[447]  G. Lip,et al.  Atenolol and fetal growth in pregnancies complicated by hypertension. , 1999, American journal of hypertension.

[448]  J. Craig,et al.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. , 2005, The Cochrane database of systematic reviews.

[449]  B. Sibai,et al.  Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. , 2003, American journal of obstetrics and gynecology.

[450]  J. Kingdom,et al.  Mid-Trimester Placentation Assessment in High-Risk Pregnancies Using Maternal Serum Screening and Uterine Artery Doppler , 2005, Hypertension in pregnancy.

[451]  T. Pickering,et al.  Principles and techniques of blood pressure measurement. , 2002, Cardiology clinics.

[452]  R. Carr-Hill,et al.  Pre-eclampsia in second pregnancy. , 1985, British journal of obstetrics and gynaecology.

[453]  A. Pastuszak,et al.  Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995. , 1997, MMWR. Morbidity and mortality weekly report.